Which Patients with AV Block Should Receive CRT Pacing?
Tanyanan Tanawuttiwat1, Alan Cheng
1Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N Wolfe Street, Carnegie 568, Baltimore, MD, 21287, USA.
Cardiac resynchronization therapy (CRT) offers benefits beyond severe heart failure. This review examines right ventricular pacing consequences and CRT
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) benefits are established in advanced systolic heart failure and prolonged QRS duration.
- Favorable outcomes have expanded from severe to milder heart failure, and now to asymptomatic left ventricular dysfunction requiring pacing.
- Right ventricular (RV) pacing may lead to pacing-induced cardiomyopathy, but not in all patients.
Purpose of the Study:
- To review the physiology and consequences of RV pacing.
- To discuss the pathophysiology of pacing-induced cardiomyopathy.
- To evaluate the benefits of CRT and factors for implantation in specific populations.
Main Methods:
- Comprehensive literature review.
- Analysis of existing clinical trial data.
- Discussion of physiological mechanisms and clinical outcomes.
Main Results:
- Biventricular pacing may be superior to RV pacing in patients with normal to mildly depressed left ventricular function requiring pacing.
- CRT non-response rates are approximately one-third.
- CRT implantation complexity entails higher risks than conventional pacemakers.
Conclusions:
- Routine CRT implantation may not be justified in the entire population requiring pacing.
- Careful consideration of patient-specific factors is crucial for CRT decision-making.
- Understanding RV pacing effects and CRT benefits is essential for optimizing patient care.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...


